Researchers customized carbon nanotubes potential deliver drugs into pancreatic cancer cells

Short carbon nanotubes delivers drug to pancreatic cancer cells

9:13 AM, 6th June 2014
customized carbon nanotubes
Researchers found that chemotherapy agents attached to nanotubes are too large to go through the pores of normal blood vessels (left), but small enough to pass through the pores of cancer-related vessels. Once through, the nanotubes can be taken up by cancer cells to deliver the drugs.

HOUSTON, US: According to researchers at Rice University and the University of Texas MD Anderson Cancer Centre, short, customized carbon nanotubes have the potential to deliver drugs to pancreatic cancer cells and destroy them from within.

Pristine nanotubes produced through a new process developed at Rice can be modified to carry drugs to tumors through gaps in blood-vessel walls that larger particles cannot fit through. The nanotubes may then target and infiltrate the cancerous cells’ nuclei, where the drugs can be released through sonication – that is, by shaking them. The research was led by Andrew Barron, Chemist, Rice University. The report appears in Royal Society of Chemistry’s Journal of Materials Chemistry B.

Most pancreatic cancer patients die within a year of diagnosis and have a five-year survival rate of 6 per cent, partially because there is no method for early detection, according to the American Cancer Society. Tumors are often inoperable and pancreatic cancer cells are also difficult to reach with chemotherapy, said co-author Jason Fleming, Professor, Surgical Oncology, MD Anderson.

“These findings are encouraging because they offer a potential delivery solution for pancreatic cancer patients whose tumors resist standard chemotherapy. There are molecular and biological barriers to efficient delivery of chemotherapy to pancreatic cancer tumors, and these nanotubes might be able to make some of those irrelevant,” said Fleming.

Rice scientists made nanotubes pure enough to modify for the purpose and small enough to squeeze through the body’s defenses, said Barron. The researchers knew from previous work that nanotubes could be modified – a process called functionalization – to carry chemotherapy agents and release them at a controlled rate through sonication. “This time, we were trying to work out how long the tubes should be and the extent of functionalization to maximize uptake by the cells,” said Barron.

“Several discoveries were key. First, Rice graduate student, alumnus and co-author Alvin Orbaek purified the carbon nanotubes of iron catalysts necessary to their growth by flushing them with chlorine. Leftover iron particles damage the tubes through oxidation. That makes subsequent use difficult,” said Barron.

The next step was to cut the nanotubes down to size. Very long nanotubes are floppy and hard to deal with, said Barron. Enrico Andreoli, Postdoctoral Research Associate in Barron’s group and lead author of the paper, used a thermal process to chop them to an average length of 50 nanometre. (A human hair is about 100,000 nanometre wide.)

“Instead of ending up with a fluffy nanotube powder, we get something that looks like a hockey puck. It’s not dense - it looks like a spongy puck - but you can cut it with a razor blade. You can weigh it and do accurate chemistry with it,” added Barron.

Barron’s lab added polyethyleneimine (PEI) to the nanotube surfaces. In lab tests, the modified tubes were easily dispersed in liquid and able to pass through barriers into live cancer cells to infiltrate the nuclei. A small-molecule variant of PEI proved to be less toxic to cells than larger versions, said Barron.

“This research shows that the particles are small enough to get inside cells where you like them to be and that they may have an increased killing advantage - but that’s still unknown,” said Fleming.

Fleming, whose work focuses on improving drug delivery for pancreatic cancer, cautioned that more research is required. “The next step will be to test this approach in mice that have allografts taken from human tumors. The architecture of these tumors will more closely resemble that of human pancreatic cancer,” added Fleming.

Co-authors of the study are Robert Hauge, a distinguished faculty fellow in chemistry, and Wade Adams, a senior faculty fellow in materials science and nanoengineering, both at Rice, and postdoctoral fellow Rei Suzuki and Manoop Bhutani, a professor of gastroenterology, hepatology and nutrition, both at MD Anderson. Barron is Rice’s Charles W. Duncan Jr.–Welch Professor of Chemistry and a professor of materials science and nanoengineering.

 

© Rice University News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


ADM to acquire WILD Flavors

DECATUR, US: Archer Daniels Midland Company (ADM) is acquiring WILD Flavors GmbH, giving ADM the ability to offer food and beverage companies a compre ...

Read more
Squid’s teeth may find use in reconstructive surgery

WASHINGTON DC, US: Tentacles of squid are loaded with hundreds of suction cups, or suckers, and each sucker has a ring of razor-sharp “teeth&rdq ...

Read more
Arkema, Omya sign distribution agreement in Europe

COLOMBES, FRANCE/OFTRINGEN, SWITZERLAND: Omya, a leading global provider and distributor of specialty chemicals, and Arkema, a leading global chemical ...

Read more
New technique to detect environmental levels of oestrogen

WELLINGTON, NEW ZEALAND: Victoria University of Wellington researchers have developed a new technique that can detect environmental levels of oestroge ...

Read more
Hospira completes acquisition of Orchid’s API, R&D facilities

LAKE FOREST, US: Hospira Inc, the world’s leading provider of injectable drugs and infusion technologies, has completed the acquisition of an ac ...

Read more
Oxea declares force majeure for intermediates at Bay City facility, US

DALLAS, US: Oxea Corporation has encountered a significant production issue at its Bay City, Texas facility, US. Due to a malfunction in the productio ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X